This page helps innovators to understand questions such as:
- How can I tell if my innovation is ready to scale across the NHS?
- What evidence and preparation are needed before attempting scale-up?
- Who are the key stakeholders involved in scaling an innovation at system level?
- What strategies can I use to scale my innovation across organisations or regions?
- What common challenges cause NHS scale-up efforts to fail, and how can I avoid them?
How to tell if an innovation is ready for NHS scale-up?
Scaling an innovation in the NHS means moving beyond isolated site-specific adoption into repeatable, sustainable implementation across multiple settings. This transition requires deliberate planning, stronger evidence, and wider system engagement than is needed for pilots or early adoption.
NHS guidance consistently highlights that many innovations fail. Not because they lack value, but because scale‑up is attempted too early, too narrowly, or without sufficient operational readiness.
Early adoption demonstrates that an innovation can work. Scale‑up demonstrates that it can work reliably, repeatedly, and at system level.
To move from early adoption to scale‑up, innovators should:
- Consolidate evidence from multiple use‑cases, not a single success story
- Clarify the implementation model so it can be reproduced elsewhere
- Confirm there is a credible route to sustainable funding and procurement
- Ensure the innovation aligns with national and system‑level priorities, not only local enthusiasm
What are the job roles typically involved in innovation scale-up?
As scale increases, decision‑making shifts from individuals and teams to organisations and systems. Successful scale‑up typically depends on shared ownership between innovators and NHS partners, with key members often including:
Senior clinical and operational leaders
To support credibility and prioritisatrion
ICB level commissioners or transformation leads
To support cross-site roll-out
Digital, information governance, and procurement teams
To support system integration and information governance
Finance leads
To confirm affordability beyond pilot funding
Implementation and improvement teams
To support operational integration and ongoing monitoring
What are the strategies and considerations for innovation scale-up?
Scale‑up is not a one‑size‑fits‑all process. It takes place at different system levels, resulting in variation in digital maturity, workforce configurations, patient populations, and governance and procurement approaches. Innovations that succeed at scale are those designed to adapt to this variation, rather than assuming uniform contexts.
Common approaches to scale-up include:
1. Within a single organisation, extending use across services or departments
- Pros: Lower risk, allows learning and adaptation
- Cons: Slower, may struggle to attract large‑scale investment
2. Across a locality or ICB, supporting system‑wide consistency
- Pros: Greater consistency, stronger impact potential
- Cons: Higher coordination burden, greater exposure if implementation fails
3. Nationally, via frameworks, national programmes or policy‑driven adoption
- Pros: Clear legitimacy, faster diffusion
- Cons: High evidence thresholds, limited flexibility for local adaptation
Factors that impact NHS scale-up
According to Q, the reasons spread fails are many and varied, but two overarching factors emerge strongly in the research literature:
- Too much focus is set on initial innovation, rather than what is required for successful adoption and scale-up.
- Spread is perceived as linear and straightforward, where an innovation can be faithfully ‘lifted’ from one setting and ‘shifted’ to another. Insufficient attention is paid to the complexity and unpredictability of adoption in different contexts.
Here are six factors that support moving from pilot to practice:
Interoperability and system integration
Many innovations are built for pilots rather than systems. Ensure solutions can be embedded within commissioning pathways, clinical workflows and existing data
infrastructure, rather than deployed as isolated tools.
Align procurement, reimbursement and regulatory requirements
This needs to be addressed early, through mapping of routes to market, funding mechanisms, and approval processes to enable fast, compliant adoption.
Build scale-up strategies alongside development
Plan for real-world implementation from the outset, including change management, scale-up milestones, and defined responsibilities, so pilots transition smoothly into
routine practice.
Support the workforce
Provide role-specific training, protected time, and hands-on implementation support to ensure frontline teams can integrate solutions without added pressure.
Demonstrate ROI using real-world evidence
Show impact on patient outcomes, operational performance, and costs in routine settings to secure buy-in and long-term funding
Prioritise aligning with system objectives
Focus on population needs and pathway-level outcomes rather than organisational priorities. Scale-up decisions are based on shared system goals to enable consistent and
scalable implementation across ICBs.
The importance of scaling at the right time
Scaling too early can create long‑term barriers rather than momentum. Common risks include:
- Insufficient evidence for system‑level or national decision‑makers – this can be mitigated by using evidence standards frameworks, for example, for digital health technologies
- Under‑resourced implementation, leading to overstretched teams and poor user experience
- Assuming one success case equals generalisability and replicability, despite contextual, pathway and population differences
- Losing credibility with NHS partners if scale‑up fails or is withdrawn
Overall, successfully scaling an innovation in the NHS requires more than demonstrating early success: it depends on strong, transferable evidence, clear implementation models, and alignment with system-level priorities. Innovators must engage a wide range of stakeholders and plan for variation across settings, ensuring their solution can be delivered reliably and sustainably at scale. Attempting to scale too early or without sufficient operational readiness can create significant barriers and undermine long-term adoption.